Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma

J Hepatol. 2023 May;78(5):1063-1072. doi: 10.1016/j.jhep.2023.01.027. Epub 2023 Feb 4.

Abstract

Cholangiocarcinoma remains an aggressive and deadly malignancy that is often diagnosed late. Intrinsic tumour characteristics and the growth pattern of cancer cells contribute to the challenges of diagnosis and chemoresistance. However, establishing an early and accurate diagnosis, and in some instances identifying targetable changes, has the potential to impact survival. Primary sclerosing cholangitis, a chronic cholangiopathy prodromal to the development of a minority of cholangiocarcinomas, poses a particular diagnostic challenge. We present our diagnostic and theranostic approach to the initial evaluation of cholangiocarcinomas, focusing on extrahepatic cholangiocarcinoma. This involves a multipronged strategy incorporating advanced imaging, endoscopic methods, multiple approaches to tissue sampling, and molecular markers. We also provide an algorithm for the sequential use of these tools.

Keywords: Bile duct strictures; Cholangiocarcinoma; Indeterminate stricture; Molecular diagnosis.

Publication types

  • Review

MeSH terms

  • Bile Duct Neoplasms* / diagnosis
  • Bile Duct Neoplasms* / pathology
  • Bile Ducts, Intrahepatic / pathology
  • Biomarkers
  • Cholangiocarcinoma* / diagnosis
  • Cholangiocarcinoma* / pathology
  • Cholangitis, Sclerosing* / diagnosis
  • Endoscopy, Gastrointestinal
  • Humans

Substances

  • Biomarkers